4. Bibliografía

4.     Bibliografía

Anacak y, Yalman D, Ozsaran Z, Haydaroglu A. Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys 2001; 50(5):1107-12.

Bentzen S. M., Tucker S. L. Individualization of radiotherapy dose prescriptions by means of an in vitro radiosensitivity assay. Radiother Oncol 1998; 46(2): 216-8.

Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 2006; 16(1):288-93.

Horwich A. The future of radiotherapy. Radiother Oncol 1990; 19, 353-56.

Hsu WL, Shueng PW, Jen YM, Wu CJ, Hwang JM, Chang LP, Chen CM, Lin LC, Teh BS. Long-term treatment results of invasive cervical cancer patients undergoing inadvertent hysterectomy followed by salvage radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59(2):521-27.

Husebye E, Hauer-Jensen M, Kjorstad K, Skar V. Severe late radiation enteropathy is characterized by impaired motility of proximal small intestine. Dig Dis Sci.1994; 39(11):2341-49.

Mackay R. I., Hendry D. H. The modelled benefits of individualizing radiotherapy patients’ dose using ce lular radiosensitivity assays with inherent variability. Radiother. Oncol 1999; 50 (1): 67-75.

Montero A, Hervás A, Morera R, Sancho S, Córdoba S, Corona JA, Rodríguez I, chajón E, Ramos A. Control se síntomas crónicos. Efectos secundarios del tratamiento con radioterapia y quimioterapia. Oncología, 2005; 28(3).

Pearse HD. The urinary bladder. Moss´Radiation Oncology 7th edition.JD Cox, editor, et al 1994.

Pinar B. Lara PC. Generalidades en oncología radioterápica (I): Radiobiología. Biocancer.com 2004.Volumen 1.

L ENT SOMA tables: Table of contents. Radiotherapy and Oncology 1995; 35: 17-60.

Safwat A, Bentzen SM, Turesson I, Hendry JH. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52(1):198-204.

Saibishkumar EP, Patel FD, Ghoshal S, Kumar V, Karunanidhi G, Sharma S. Results of salvage radiotherapy after inadequate surgery in invasive cervical carcinoma patients : A retrospective analysis. Int J Radiat Oncol Biol Phys 2005; 63(3):828-33.

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31(5):1341-6.

Davidson SE, Burns MP, Routledge JA, Swindell R. The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales. Radiotherapy and Oncology 2003; 68(3):241-47.

Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, Nadalin W. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy :retrospective analysis of results and variables. Int J Radiat Oncol Biol Phys 2003; 55(3):695-706.

Trotti A, Byhardt R, Stetz R, Gwede C, Corn B, Fu K, Gunderson L, Mc Cormick B, Morris M, Rich T, Shipley W, Curran W. Common toxicity criteria: versión 2.0 an improved referent for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47(1):13-47.

Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13(3):176-81.

Tucker S. L., Turesson I. and Thames H. D. Evidence for individual differences in the radiosensitivity of human skin. Europ. J. Cancer 1992; 28 A: 1783-91.

Tucker S. L., Geara F. B., Peters L. J. and Brock W. A. How much could the radiotherapy dose be altered for individual patients, based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol 1996; 38: 103-13.

Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother. Oncol 1989; 15: 217-26.

Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 1990; 19(6):1569-74.

Turesson I, Nyman J, Holmberg E, Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients.Int J Radiat Oncol Biol Phys 1996; 36(5):1065-75.

Withers HR. Biological basis of radiation therapy for cancer. Lancet 1992; 339(8786):156-9.Review.

Yeoh E, Horowitz M, Russo A, Muecke T, Ahmad A, Robb T, Chatterton B. A retrospective study of the effects of pelvic irradiation for carcinoma of the cervix on gastrointestinal function. Int J Radiat Oncol Biol Phys 1993; 26(2):229-37.